Investing Before the Future Becomes Obvious
Every breakthrough starts before the world recognises its significance. Rhea exists to identify that moment, backing exceptional entrepreneurs and transformative technologies before they become obvious, and helping build the next generation of globally competitive life sciences companies.
About
Rhea BioVentures is a European specialist life sciences venture capital fund investing in cutting-edge innovation that can change the lives of patients.
We partner with visionary entrepreneurs advancing the future of drug development through breakthrough therapies and the technologies, tools and services that enable the discovery, development and delivery of new medicines.
Our conviction is that transformative life sciences companies are built on three essential pillars: scientific excellence, strategic execution and market alignment from day one.
Companies Building Tomorrow's Healthcare.
We're currently building our investment portfolio. Check back soon for updates on the companies we support.
"Rhea Bioventures has been more than an investor - they've been a strategic partner throughout our growth journey. Their scientific expertise and long-term perspective have been invaluable."
Founder, Livables
"Their combination of deep life sciences knowledge and commercial insight helped us navigate key milestones with confidence."
Co-founder, Healthcare startup
"Working with the Rhea Bioventures team has provided us with access to an exceptional network of industry experts and strategic partners."
CEO, Biotechnology Company
Latest Insights.
Latest Insight
Rhea news
A New Digital Home for Rhea Bioventures
We're pleased to launch the new online home of Rhea Bioventures. Our redesigned website reflects our commitment to supporting pioneering life sciences companies and provides a platform to share our investment focus, portfolio, insights, and latest news.
